ESC 365 - Mortality risk of chronic heart failure patients according to non-invasive lung impedance and New York heart association class in the impedance-HF trial

HFA Premium Access

Mortality risk of chronic heart failure patients according to non-invasive lung impedance and New York heart association class in the impedance-HF trial

Session: Poster Session 3 - Prognosis

Topic: Prognosis

Speaker: Professor M. Kleiner Shochat (Hadera, IL)

Event: HEART FAILURE 2016

Congress Presentation

Add to my library

About the speaker

Professor Michael Kleiner Shochat

Hillel Yaffe Medical Center, Hadera (Israel)

3 presentations

1 follower

18 more presentations in this session

Two-year follow-up of patients with acute myocardial infarction with ST elevation and new onset atrial fibrilation in relation to fibrinolytic therapy or primary PCI

Speaker: Professor A. Boskovic (Podgorica, ME)

Predictors of hospital mortality in a specific population of women with acute myocardial infarction and an ejection fraction lesser than 40%

Speaker: Doctor C. Costa (Setubal, PT)

Cardiac cachexia and its impact on survival in Asian patients

The heart failure marker TWEAK predicts survival in critically ill patients

Speaker: Doctor M. Luedde (Giessen, DE)

Influence of cardiopulmonary exercice test results on mortality after cardiac transplant

Speaker: Doctor P. Freitas (Carnaxide, PT)

Access the full session

Poster Session 3 - Prognosis

Speakers: Professor M. Kleiner Shochat, Professor A. Boskovic, Doctor C. Costa, Doctor M. Luedde, Doctor P. Freitas

About the event

HEART FAILURE 2016

21 May - 24 May 2016

Sessions Presentations

Congress

ESC 365 is supported by

novartis

Explore sponsored resources